T. Guillaume

Drug-resistant cytomegalovirus in transplant recipients: a French cohort study

Sébastien Hantz, F. Garnier-Geoffroy, Marie‐Christine Mazeron et al. · Journal of Antimicrobial Chemotherapy · 2010 · 163 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Thrombopoietic effects and toxicity of interleukin-6 in patients with ovarian cancer before and after chemotherapy: a multicentric placebo- controlled, randomized phase Ib study

Véronique D’Hondt, Yves Humblet, T. Guillaume et al. · Blood · 1995 · 97 citations · Full text

Medicine, Gynecology, Oncology +17

Dose-dependent interleukin-3 stimulation of thrombopoiesis and neutropoiesis in patients with small-cell lung carcinoma before and following chemotherapy: a placebo-controlled randomized phase Ib study.

Véronique D’Hondt, P. Weynants, Yves Humblet et al. · Journal of Clinical Oncology · 1993 · 67 citations

Medicine, Oncology, Pharmacology +10

Defective cytokine production following autologous stem cell transplantation for solid tumors and hematologic malignancies regardless of bone marrow or peripheral origin and lack of evidence for a role for interleukin-10 in delayed immune reconstitution.

T. Guillaume, M Sekhavat, D. B. Rubinstein et al. · PubMed · 1994 · 33 citations

Life Sciences, Cell Biology, Immunology +15

Effects of escalating doses of recombinant human interleukin-2 in correcting functional T-cell defects following autologous bone marrow transplantation for lymphomas and solid tumors.

A Bosly, T. Guillaume, Pauline Brice et al. · PubMed · 1992 · 25 citations

Life Sciences, Immunology, Oncology +15